PP
TYRA icon

PDT Partners’s Tyra Biosciences TYRA Stock Holding History

PDT Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$820K Sell
25,684
-16,600
-39% -$549K 0.04% 346
2026
Q1 		$1.62M Hold
42,284
– – 0.1% 271
2025
Q4 		$1.11M Sell
42,284
-1,026
-2% -$18.8K 0.07% 338
2025
Q3 		$606K Hold
43,310
– – 0.04% 426
2025
Q2 		$414K Buy
+43,310
New +$412K 0.02% 548
2025
Q1 		– Sell
-20,359
Closed -$283K – 859
2024
Q4 		$283K Buy
+20,359
New +$369K 0.03% 592
2024
Q3 		– Sell
-15,306
Closed -$245K – 826
2024
Q2 		$245K Buy
15,306
+3,132
+26% +$53.9K 0.02% 584
2024
Q1 		$200K Buy
+12,174
New +$200K 0.02% 576

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

PDT Partners's TYRA Position: Q2 2026 in Review

PDT Partners reduced its Tyra Biosciences (TYRA) stake by 39% in Q2 2026, selling an estimated $549K and leaving 25,684 shares worth $820K. The position accounts for 0.04% of the portfolio, ranked #346.

PDT Partners first reported a position in TYRA in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.62M in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • PDT Partners held 25,684 shares of Tyra Biosciences worth $820K as of Q2 2026.
  • PDT Partners sold 16,600 Tyra Biosciences shares in Q2 2026, an estimated $549K.
  • Tyra Biosciences made up 0.04% of PDT Partners's portfolio in Q2 2026, its #346 holding.
  • PDT Partners first reported a position in Tyra Biosciences in Q1 2024 and has held it in 8 quarters since.
  • PDT Partners's Tyra Biosciences position peaked at $1.62M in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.